CHENGDU, China, Sept. 23, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the 'Company') announced that a new drug application (NDA) for the Company's small molecule rearranged ...

IMNN-001 continues to show a favorable safety profile.

OVATION 3 pivotal Phase 3 trial is currently advancing IMNN-001, with several patients being treatedLAWRENCEVILLE, N.J., Sept (GLOBE ...

The medium, which is designed for high density perfusion culture, is available in a variety of media package options for continuous processing.

FUJIFILM Biosciences launches BalanCD HEK293 Perfusion A to boost scalable viral vector production for gene therapy.

IMUNON (IMNN) announced that new translational data from the Phase 2 OVATION 2 Study of IMNN-001, its investigational therapy for the treatment of ...

Gene therapy offers the possibility of addressing cancer at its molecular roots by targeting disease-causing genes rather than relying solely on surgery, chemotherapy, or radiotherapy.

Cell migration in confined environments leads to nuclear envelope rupture, chromatin leakage and genomic instability. This ...

Intracellular Signaling Domain: Activates the T cell upon antigen engagement. It usually contains the CD3ζ chain or CD3ε derived from the T-cell receptor, plus costimulatory domains such as CD28 or ...